Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.
about
pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGNRespiratory viruses other than influenza virus: impact and therapeutic advancesChloroquine is a potent inhibitor of SARS coronavirus infection and spread.Animal models for SARS and MERS coronavirusesMolecular pathology of emerging coronavirus infectionsEarly Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus InfectionA crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injuryEmerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious DiseasesSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionVaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variantsHuman monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutantsA decade after SARS: strategies for controlling emerging coronavirusesThe role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.Quantifying the early immune response and adaptive immune response kinetics in mice infected with influenza A virus.PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccineB-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.Cynomolgus macaque as an animal model for severe acute respiratory syndrome.Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS.A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection.SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism.Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceAged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humansEvasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates.Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.Humanized mice develop coronavirus respiratory disease.A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunityA severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine coronavirusSingle amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Effect of human movement on airborne disease transmission in an airplane cabin: study using numerical modeling and quantitative risk analysis.Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.
P2860
Q24563490-0C8E26F8-C5CD-4154-94D2-2AA96757C64EQ24655957-E3515FD5-48EF-4492-AFCE-89A2D73E8680Q24815979-64579BCD-BEE7-4833-99A9-3C2BE906FA23Q26799857-ED19EB0B-09A6-4CD2-8DF2-61EAB345DF11Q26824463-87C6DD7C-BDCA-4A81-993D-4DEBCA69B304Q27488870-9C87A040-2938-40DC-800E-489879F884A3Q28260798-12FE4853-29BC-4F6A-BEB4-0C16CC2D5D44Q28383084-11186441-43A0-4F73-8699-AB7714CFED06Q28383088-1938A86B-4F72-4D0B-A808-EA0CE1B6CFEAQ28764574-E304F0DD-AF03-444D-A08D-62E4D473342AQ28768526-2F47A0D9-861E-4BAF-8481-B5FCD9F7EE09Q28817689-D1CB6C8D-4D28-4DCD-846F-6EF9D8E31B06Q30234893-56613668-CA14-49E9-BA77-AF9FAFF86317Q30360085-A6577513-66D1-410A-9E3C-5AEF057A9346Q30378994-063EBC7D-56CF-4EEB-9389-C215E5EC2F38Q30388405-CC46D14F-7FAA-4D62-B01C-A2642268370DQ30401566-E79802A7-B06E-4E14-BD88-00DDDFC862CFQ30430552-692BBE36-9187-47D8-ABFC-DD54710B6A44Q31149856-0285483F-59FF-4DDC-AFDC-CCABC535B1DAQ33210858-DF132918-AE3A-4B82-BCC4-86861DE95875Q33239453-CD7BC26C-4977-4557-ACA7-44E367D28944Q33242774-65BFA4A2-9EFE-4A45-9A36-EE1C00BDDEC4Q33269158-FF59B62D-79CD-4D2B-9D41-8D14A0E50606Q33293891-6FFCC534-96EF-4208-94E3-C97821D8BDDEQ33553351-906B3601-A1D8-470C-B768-84542A8E8AF3Q33614444-4F7D8FDF-25CF-4325-83BD-88D4C10425B0Q33695621-949F47AD-57BF-4AA9-BA66-28841F209D4FQ33696283-6B93042A-ACAA-4B4C-98AA-A1B6AA682CD8Q33755105-56AC39CA-87F4-4AB9-A59F-F7B2E22FC1FFQ33756740-D4FF6220-DE13-498C-8611-185D3CE91A1DQ33780455-C659261A-0ED2-4313-AC4B-7A5643721092Q33781814-61DFAD5D-98D5-499D-98E6-86666EC851DFQ33841118-5AB6EF6C-9D5F-4AE7-B64A-CD266B248C88Q33852205-AAB5230F-D00E-495F-88B1-819DFC28858AQ33904997-07C4B93E-614F-4991-8A0A-A166ADFBD366Q33930434-24E6637E-81A3-4035-9246-1DF62A4E59D2Q33987417-A3AFE4EA-2A4C-470C-B2E7-959DFB814B72Q34015988-4EA75448-2485-438C-9713-A75D3919DFB4Q34048444-93EC7AA3-DE54-4F49-8E9B-F5F63C4D8BFAQ34142905-AB889572-BAB0-46E0-9CBF-ADF155B7B4DE
P2860
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prior infection and passive tr ...... the respiratory tract of mice.
@en
Prior infection and passive tr ...... the respiratory tract of mice.
@nl
type
label
Prior infection and passive tr ...... the respiratory tract of mice.
@en
Prior infection and passive tr ...... the respiratory tract of mice.
@nl
prefLabel
Prior infection and passive tr ...... the respiratory tract of mice.
@en
Prior infection and passive tr ...... the respiratory tract of mice.
@nl
P2093
P2860
P1433
P1476
Prior infection and passive tr ...... the respiratory tract of mice.
@en
P2093
Brian Murphy
Gary Fahle
Josephine McAuliffe
Kathleen Tatti
Leatrice Vogel
Michelle Packard
Steven Fischer
Wun-Ju Shieh
P2860
P304
P356
10.1128/JVI.78.7.3572-3577.2004
P407
P577
2004-04-01T00:00:00Z